跳至主要内容
临床试验/NCT05609123
NCT05609123招募中不适用

Endothelial Glycocalyx Status and Damage in Brain Death Organ Donors

University Hospital Hradec Kralove2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
Markers of endothelial glycocalyx damage

研究概览

简要总结

The study aims the assessment of endothelial glycocalyx (EG) degradation in deceased organ donors. There is a lack of organs for the transplantation program. By the description of the EG status, we can open room for organ optimization before transplantation and improve the organ function after transplantation in marginal donors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients in critical condition declared as brain dead by clinical examination

排除标准

  • 未提供

研究组 & 干预措施

Brain dead organ donors

Patients with clinically proven bain death were assigned to the paraclinical confirmatory investigation of the brain death and subsequently accepted into the transplantation program.

干预措施: Endothelial glycocalyx damage assessment (Diagnostic Test)

结局指标

主要结局

Markers of endothelial glycocalyx damage

时间窗: baseline at the time of inclusion

Levels of syndecan-1 in serum and urine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Astapenko, MD, PhD, MBA

Deputy Head for Science and Research

University Hospital Hradec Kralove

研究点 (2)

Loading locations...

相似试验